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ABSTRACT
Background: Fatigue and attentional decline limit the duration of many therapy sessions in older adults poststroke. Transcranial direct
current stimulation (tDCS) may facilitate participation in rehabilitation, potentially via reduced fatigue and improved sustained attention
poststroke.
Objective: To evaluate whether tDCS results in an increase in the number of completed rehabilitation therapy sessions in stroke
survivors.
Methods: Nineteen participants were randomly allocated to receive 10 sessions of 2-mA anodal (excitatory) tDCS, or sham tDCS, applied
to the left dorsolateral prefrontal cortex (DLPFC) for 20 minutes within 1 hour prior to the first rehabilitation therapy session of the day. After a
2-day washout period, participants then crossed-over. Researchers applying the tDCS, and those recording measures were blinded to
group allocation. The number of first rehabilitation therapy sessions completed as planned, as well as the total duration of rehabilitation therapy, were used to determine the influence of tDCS on participation in stroke rehabilitation.
Results: The total number of first therapy sessions completed as planned did not vary according to group allocation (111 of 139 sessions
for tDCS, 110 of 147 sessions for sham treatment; chi-square 1.0; P = .31).
Conclusions: Our results suggest that, while tDCS to the DLPFC was well tolerated, it did not significantly influence the number of completed rehabilitation therapy sessions in stroke survivors.
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Introduction

Attention deficits may affect the ability of older adults to
engage in rehabilitation poststroke.1 In addition, fatigue is
very common poststroke. Fatigue is a complex impairment.
Reduced cortical excitability is postulated to be one factor
contributing to poststroke fatigue.2 Thus, fatigue and attentional decline may limit rehabilitation therapy session duration in older adults poststroke.1,2 Because rehabilitation is
typically offered only in the initial months poststroke, it is
critical that stroke survivors engage in as much therapy as
possible during this time. The mean physiotherapy session
treatment duration in a large published series was 38 ± 17
minutes.3 We identified that many patients, particularly those
with severe stroke, are not able to stay alert for the duration of
their therapy sessions and often cannot complete their therapy due to fatigue, attentional decline, or loss of concentration. In local audit data, the mean session duration of therapy
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sessions among 14 stroke survivors in the Bentley Hospital
Stroke Rehabilitation Unit (SRU) was 34 ± 23 minutes.
These published international data, and our local data, are
both far below the recommended durations of rehabilitation
therapy (at least 3 hours a day of scheduled therapy)4 suggesting the importance of investigating interventions that can
improve duration and the number of therapy sessions.
There is preliminary evidence that noninvasive brain stimulation (NIBS) can enhance alertness and attention poststroke.5,6 Compared with other NIBS techniques such as
repetitive transcranial magnetic stimulation, transcranial direct
current stimulation (tDCS) offers a reliable safety profile,7
affordability, ease of application, and sophisticated sham mode
which allows for blinded control in clinical trial settings.8
Transcranial direct current stimulation is one of the most commonly used adjuvant NIBS techniques and has been shown to
augment the recovery of upper limb movement and function
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and to assist in the management of dysphasia, visual neglect,
and language dysfunction poststroke.9
Transcranial direct current stimulation acts to modulate
cortical excitability by application of weak electrical currents
(up to 2 mA)10 via electrodes applied to the scalp. Depending
on the current polarity, neuronal firing rates increase or decrease
due to changes in resting membrane potentials, with anodal
tDCS increasing the likelihood of neuronal firing and cathodal
tDCS decreasing the likelihood of neuronal firing.11 It has
been shown to be safe even when applied acutely (within two
days) to the stroke-affected cortex.12 Previous research has
shown stroke survivors demonstrated greater accuracy, but not
speed, on a test of executive attention following one session of
tDCS compared with sham stimulation.5,6 The application of
tDCS to the DLPFC has been shown to enhance cognitive
functions including working memory, visuomotor coordination, and decision-making in healthy individuals,13,14 and in
people with dementias or Parkinson disease.15-17 The aftereffects of tDCS on cortical excitability are likely modulated by
N-methyl-d-aspartate (NMDA) receptor-dependent processes, and a number of investigations have shown that longer
term changes can be induced in neuronal networks, including
cognitive-attentional networks.9
The main adverse effect of tDCS which has been documented include a mild tingling or itching sensation, usually at
the site of the cathodal electrode, which is common at the
beginning of stimulation.7 An expert panel have provided recommendations for clinical and research use which clearly set
out safety parameters.18
The available data suggest that tDCS may reduce fatigue
and improve sustained attention poststroke. However, there are
no data on longer term effects of tDCS with regard to sustained attention or clinical benefits, such as improved participation in rehabilitation, in older stroke survivors. We, therefore,
designed the present study to test the hypothesis that tDCS
applied to the DLPFC, compared with sham treatment, would
be associated with an increase in the duration of rehabilitation
therapy sessions in stroke survivors.

implant, and use of NMDA receptor antagonists or calcium
channel blockers (which limit the beneficial effect of tDCS).
Participants were randomly allocated to receive 10 sessions (ie,
each weekday for 2 weeks) of 2-mA anodal (excitatory) tDCS
or sham tDCS, applied to the left DLPFC for 20 minutes.
After a 2-day washout period, participants then crossed-over to
the other study condition.
Transcranial direct current stimulation was applied
within 1 hour prior to the first daily therapy session.
Transcranial direct current stimulation was applied in
accordance with published guidelines for the safe use of
tDCS.5,18 Transcranial direct current stimulation was delivered by a constant current electric stimulator via a pair of
rubber surface electrodes overlying a saline infused pad.
The anode was applied to the left DLPFC (according to
the International EEG 10/20 System),19 and the cathode
was applied to the contralateral supraorbital area. Anodal
stimulation consisted of a 30-second current ramp up followed by 19 minutes of constant current stimulation (2 mA)
and a 30-second ramp down to zero current (20-minute
total protocol)10,20,21; sham stimulation consisted of a
30-second current ramp up (2 mA) followed immediately
by a 30-second ramp down to zero current. Researchers
applying the tDCS and those recording measures were
blinded to group allocation. Outcome measures were (a)
whether the first rehabilitation therapy session of the day
immediately following application of tDCS was completed
as planned and (b) the cumulative duration (in minutes) of
rehabilitation sessions.
We aimed to enrol at least 18 participants to provide 0.8
power at the 0.05 level to detect a treatment effect of an increase
in 17 minutes of therapy time with anodal tDCS compared
with sham. Categorical frequency data (ie, sessions completed
as planned) were categorised as ‘completed’ or ‘not complete’
and compared using the chi-square statistic. A paired sampled
t test was used to determine within-subject differences in total
therapy time according to group allocation.

Materials and Methods

One hundred seventy consecutive patients were screened. The
reasons for screen failure were length of stay anticipated to be
⩽1 month (n = 64), diagnosis not ischaemic stroke (n = 48),
treatment with calcium channel blockers (n = 16), which interfere with tDCS effects, and other (n = 13). Ten patients declined
participation. The 19 remaining participants (13 female; 6
male; median age 79 [70.5, 82.5] years) were recruited.
The total number of planned first therapy sessions completed did not vary according to group allocation (111 of 139
therapy sessions completed as planned following tDCS cf 110
of 147 therapy sessions completed as planned in the sham condition; chi-square 1.0; P = .31). Similarly, the proportion of
patients completing all first therapy sessions of the day was not
different according to group allocation (4 of 16 participants
receiving tDCS; 8 of 18 participants receiving sham;

The study was approved by the Royal Perth Hospital Human
Research Ethics Committee (2016-027) and prospectively registered (ACTRN12616000254493). An investigator provided
all participants with a written information sheet, a simplified
written summary of the information sheet designed for people
experiencing communication impairments, and verbal information about the study. All participants provided written
informed consent.
Older adults (60+ years) admitted to the Bentley Hospital
SRU with a diagnosis of ischaemic stroke, who clinical staff
judged were likely to be inpatients ⩾1 month, were eligible to
participate. Exclusion criteria included prestroke history of
fatigue-related syndromes, unstable comorbid medical or psychiatric disease, history of seizures or metallic foreign body

Results
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chi-square = 1.4; P = .24). The within-subject difference in
therapy time according to sequence allocation was 25 minutes
(95% confidence interval [CI] −80, 130; P = .61).

Discussion

This research evaluated a novel use of an established therapeutic intervention (tDCS) to address an area of high clinical
need, namely optimising the ability of older adults to engage
in rehabilitation poststroke. We found that use of tDCS is feasible in a clinical setting of subacute stroke rehabilitation but
did not find evidence of increased engagement in therapy in
this clinical population. There are a number of potential reasons for this finding. Stroke is a heterogeneous disease, and it
is possible that subgroups of stroke survivors may have benefitted from the intervention, but this was not able to be identified due to the small sample size of this feasibility study.
Individuals who were in the subacute recovery phase poststroke who were anticipated to be able to complete the intervention as an inpatient (minimum 1-month length of stay)
were recruited. These patients tend to have severe lesions and
poststroke deficits; consequently, the findings may not be generalisable to other stroke survivors, or to stroke survivors earlier in the course of their recovery. We did not specify inclusion
of patients with a specific aetiology of ischaemic stroke; however, none of the included patients had a diagnosis of haemorrhage. It could also be the case that the dose of treatment (10
sessions, which we judged would be feasible in a cross-over
design) in our study was insufficient, given that some previous
studies have used up to 30 sessions, and that there are some
data10 supporting a dose-response relationship. Similarly, we
chose a 2-day washout, which may have been insufficient.
Future studies may consider use of a higher numbers of sessions over a longer time period or tDCS applied simultaneously with rehabilitation intervention. Finally, we used a
clinical endpoint (duration of rehabilitation sessions) as the
primary outcome. More sensitive measures of sustained attention, fatigue, and other factors limiting participation in therapy, including self-report measures, may be required to
demonstrate benefits in subgroups of stroke survivors with
fatigue/attention deficits.
The strengths of our study are that participants and assessors were blinded to group allocation, and the inclusion of a
sham condition, so that participants acted as their own control.
The major limitation of our study is the potential for random
error, and limited generalisability, because of the small number
of participants. These limitations are unfortunately common in
many of the studies in this field. There were also methodological limitations; eg, we did not confirm successful blinding.
Further studies with carefully selected subgroups of stroke survivors should be considered. Measurement of fatigue and
attention at multiple time points in each 24-hour period would
have been desirable, but was not possible in this feasibility
study. This study shows that tDCS is feasible for in-patients,
and future work should directly measure fatigue and attention
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to understand whether tDCS can increase engagement in therapy via reduction in fatigue and increase in attention.
In conclusion, to our knowledge, this is the first study to
explore the use of tDCS to specifically improve attention and
reduce the effect of fatigue on treatment tolerance in older
stroke survivors. Our results suggest that, while tDCS to the
DLPFC was feasible to apply during subacute stroke rehabilitation, and was well tolerated, it did not significantly influence
fatigue or alertness which are major contributors to a patient’s
engagement in therapy. Larger studies are needed to make
definitive conclusions about any potential benefit of tDCS to
the DLPFC on alertness poststroke in older stroke survivors.
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